
About Juan Lopez-Belmonte Lopez & family
Juan Lopez-Belmonte Lopez is chairman of the board of Laboratorios Farmaceuticos Rovi, a Madrid-based biotechnology firm.
His son Juan Lopez-Belmonte Encina is CEO of the company; two other sons serve as vice presidents of Rovi, as the company is known.
Lopez-Belmonte and his sons together own more than 60% of the Madrid-listed company.
In July 2020, Rovi and U.S. firm Moderna agreed to collaborate on manufacturing and packaging Moderna's Covid-19 vaccine candidate.
The U.S. Food and Drug Administration gave emergency authorization to Moderna's Covid-19 vaccine in December 2020 and the EU soon followed suit.
Personal stats
Citizenship
SpainSource of wealth
pharmacueticalsSelf-made
inherited and growingJuan Lopez-Belmonte Lopez & family’s fortune is worth

41K
troy ounces of gold

38K
median U.S. household

25K
median U.S. income

0.049%
U.S. credit card volume

0.01%
GDP of the United States

0.007%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
MADRID | ROVI-ES
Laboratorios Farmaceuticos RoviImages © Forbes.com. All rights reserved.